3654 results for «372»
3654 results
Featured cases - Strategic approaches in mitral regurgitation
24 Nov 2024 – From PCR London Valves 2024
Immerse yourself in this featured session showcasing strategic approaches in the management of mitral regurgitation. Explore a range of complex cases, including percutaneous annuloplasty with a novel device in functional mitral regurgitation, the management of mitral annulus cavity and regurgitation post-healed endocarditis, simultaneous management of two...
Featured research - Tricuspid valve (Part 2)
24 Nov 2024 – From PCR London Valves 2024
Delve into the latest research on tricuspid valve interventions in this second featured session from PCR London Valves 2024. Gain insights into the characteristics and outcomes of severe isolated tricuspid regurgitation across different treatment strategies, the issue of valve thrombosis after TTVR, the one-year robustness of...
Featured research - Aortic valve (Part 2)
24 Nov 2024 – From PCR London Valves 2024
This second part of the featured research session on aortic valve interventions delves into a wide range of topics, including vascular complications, valve-in-valve TAVI, coronary protection strategies, predictors of mortality, and innovative techniques. Discover the latest advancements and insights from cutting-edge research.
Featured cases - TAVI in bicuspid valve anatomy (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Explore a unique collection of featured TAVI cases in bicuspid valve anatomy. Witness the successful navigation of complex scenarios, including the treatment of severely calcified bicuspid valves, handling of extreme annular dimensions, and the utilization of specialized techniques like antegrade transseptal TAVI. Gain insights that can...
Featured cases - TAVI in SAVR (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Delve into a collection of compelling TAVI cases involving prior surgical aortic valve replacement (SAVR). Witness the nuances of valve-in-valve TAVI, including the importance of pre-dilation and the challenges of uncrossable valves. Gain insights into managing severe aortic regurgitation in failed bio-Bentall procedures and navigating TAVI...
Featured cases - Complications of mitral TEER
24 Nov 2024 – From PCR London Valves 2024
Delve into a series of compelling cases highlighting complications associated with mitral transcatheter edge-to-edge repair (TEER) procedures. Witness the management of leaflet perforation, single leaflet detachment, and left atrial perforation. Explore innovative bailout strategies and the challenges posed by M-TEER. This session offers valuable lessons to...
Rapid-Fire - Rare and unusual (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Immerse yourself in a captivating collection of rare and unusual interventional cardiology cases. Witness the first known case of dual valve-in-valve replacement in caval valve implantation, the management of device-related allergic reactions, and the treatment of left atrial thrombi associated with appendage occlusion devices. Explore solutions...
How to establish a mitral TEER programme
24 Nov 2024 – From PCR London Valves 2024
Ready to start your journey toward establishing a mitral TEER programme? This video covers everything you need to know—from understanding the contemporary role of TEER in managing mitral regurgitation to building a Heart Team and referral network.
Learn how to find your first cases, select the right...
Coronary sinus reducer for microvascular angina
28 Feb 2020
A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation – The WATCH-TAVR Trial
26 Oct 2023
Panos Xaplanteris provides his take on WATCH-TAVR results which were presented by Samir R. Kapadia at TCT Congress 2023.
Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial
Author
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis
22 Mar 2022
Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022.
Author
Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3
02 Apr 2025
Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.
Author
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
29 Mar 2025
Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.
Author
Author
